Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REVOLUTION-MEDICINES-INC-102616325/news/Revolution-Medicines-to-Present-New-Preclinical-Data-from-RAS-ON-Inhibitor-Programs-at-AACR-NCI-E-36557555/?utm_source=whatsapp&utm_medium=social&utm_campaign=share